Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting with activist investor Starboard Value, Pfizer's former CEO and CFO publicly changed their tune after being threatened with litigation by Pfizer,
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current ...
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist ...
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback